SNY News and Press, Sanofi From 05/13/24

2024-05-13 03:29:35 ET More on Sanofi Sanofi Q1: Wait And See For Now (Downgrade) Sanofi: Q1 Earnings Reflect Growth And Strategic Acquisitions (Rating Upgrade) Sanofi 2024 Q1 - Results - Earnings Call Presentation Novavax surges as Sanofi COVID vaccine deal ...

If approved, Dupixent would be the first treatment in the U.S. indicated for adolescents aged 12-17 years with inadequately controlled CRSwNP, a condition driven in part by underlying type 2 inflammation that obstructs the sinuses and nasal passages and can lead to a loss of sense of smell ...

2024-05-12 13:07:18 ET Summary Novavax announced Q1 2024 results with a beat on EPS and a miss on revenue, causing a surge in premarket trading. Novavax finalized a licensing agreement with Sanofi worth up to $1.2B, boosting its COVID-19 vaccine commercial performance. The San...

2024-05-11 23:18:05 ET Summary IGM Biosciences is developing a different class of antibodies to improve on the classic IgG antibodies. Their most advanced project, aplitabart, is being tested in a clinical trial for metastatic colorectal cancer. The company has a decent cash p...

2024-05-11 07:59:50 ET More on Novavax Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade) Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference -...

2024-05-10 14:13:46 ET More on Alphabet, Recursion, etc. Recursion Pharmaceuticals, Inc. (RXRX) Q1 2024 Earnings Call Transcript Bronte Capital - Alphabet: Could Not Find Anything We Liked More Google: The Recent Surge Is Far From Over CrowdStrike, Google exp...

2024-05-10 13:50:51 ET Summary Novavax, Inc.'s Sanofi partnership provides much-needed financial support via upfront and milestone payments, stabilizing its finances. Combination vaccines are set to be an essential market, but competitors like Pfizer and Moderna are further along....

2024-05-10 13:08:23 ET Shares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report, however, driving the bulk of today's oversize gain -- it's the announcement made in conjunction with it. Th...

2024-05-10 12:03:06 ET More on STOXX Europe 600 Index: Dollar Is Softer Ahead Of The Employment Report Japan Drives Home Message Yen Retreats, While Stronger EMU GDP Underscores Nascent Recovery And Lifts The Euro Five reasons to prefer the European market vs...

2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...